Analysts Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Price Target at $779.45
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-seven research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation, fifteen have assigned a buy recommendation and three have […]
3 Jan 05:06 · The Cerbat Gem